Redmile Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Redmile Group’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-557,800	Closed	-$18.5M	–	87
2020 Q1	$18.5M	Sell	557,800 -10,100	-2%	-$401K	0.52%	46
2019 Q4	$24.9M	Buy	+567,900	New	+$21M	0.6%	45
2019 Q2	–	Sell	-300,000	Closed	-$10M	–	96
2019 Q1	$10M	Buy	+300,000	New	+$9.97M	0.29%	56

Other funds holding SWAV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AGM

Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Redmile Group's SWAV Position: Q2 2020 in Review

Redmile Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2020, closing a stake of 557,800 shares — an estimated $18.5M sold.

Redmile Group first reported a position in SWAV in Q1 2019 and held it in 3 quarters. The position peaked at $24.9M in Q4 2019. 140 funds tracked by Wall St. Rank hold SWAV as of Q2 2020.

Redmile Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Redmile Group sold 557,800 Shockwave Medical, Inc. Common Stock shares in Q2 2020, an estimated $18.5M.
Redmile Group first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Redmile Group's Shockwave Medical, Inc. Common Stock position peaked at $24.9M in Q4 2019.
140 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2020.

Based on Redmile Group's 13F filing for Q2 2020, filed 14 Aug 2020.